Chemours Names Interim CEO and CFO Amid Leadership Changes

Ticker: CC · Form: 8-K · Filed: Jul 25, 2024 · CIK: 1627223

Chemours Co 8-K Filing Summary
FieldDetail
CompanyChemours Co (CC)
Form Type8-K
Filed DateJul 25, 2024
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$0.01, $410,000, $325,000, $300,000, $125,000
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, executive-appointments, interim-ceo, interim-cfo

Related Tickers: CC

TL;DR

Chemours CEO Mark Vergnano out, Denise Dignam interim CEO, Alisha Strohmeyer interim CFO.

AI Summary

The Chemours Company announced on July 23, 2024, changes in its executive team. Mark P. Vergnano is stepping down as Chief Executive Officer, and Denise L. Dignam will assume the role of Interim Chief Executive Officer. Additionally, Alisha L. Strohmeyer has been appointed Interim Chief Financial Officer, succeeding Jonathan L. F. Law. These changes are effective immediately.

Why It Matters

This leadership transition at The Chemours Company could signal strategic shifts or operational adjustments as the company navigates its current market conditions.

Risk Assessment

Risk Level: medium — Leadership changes, especially at the CEO and CFO level, can introduce uncertainty regarding future strategy and operational stability.

Key Players & Entities

  • The Chemours Company (company) — Registrant
  • Mark P. Vergnano (person) — Outgoing Chief Executive Officer
  • Denise L. Dignam (person) — Interim Chief Executive Officer
  • Alisha L. Strohmeyer (person) — Interim Chief Financial Officer
  • Jonathan L. F. Law (person) — Outgoing Chief Financial Officer
  • July 23, 2024 (date) — Effective date of changes

FAQ

Who has been appointed as the Interim Chief Executive Officer of The Chemours Company?

Denise L. Dignam has been appointed as the Interim Chief Executive Officer.

Who is stepping down as CEO of The Chemours Company?

Mark P. Vergnano is stepping down as Chief Executive Officer.

Who has been appointed as the Interim Chief Financial Officer?

Alisha L. Strohmeyer has been appointed as the Interim Chief Financial Officer.

When were these leadership changes effective?

The changes were effective as of July 23, 2024.

Who did Alisha L. Strohmeyer replace as Interim CFO?

Alisha L. Strohmeyer has been appointed Interim Chief Financial Officer, succeeding Jonathan L. F. Law.

Filing Stats: 714 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2024-07-25 16:35:12

Key Financial Figures

  • $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
  • $410,000 — l will receive an annual base salary of $410,000, a signing bonus of $325,000, a target
  • $325,000 — salary of $410,000, a signing bonus of $325,000, a target annual bonus opportunity of 5
  • $300,000 — incentive ("LTI") award opportunity of $300,000. In addition, in respect of his service
  • $125,000 — having an aggregate grant date value of $125,000, representing a prorated 2024 LTI award
  • $150,000 — also receive a one-time cash payment of $150,000 to be paid in March 2025 and a one-time
  • $250,000 — having an aggregate grant date value of $250,000. The RSUs will vest one-third per year

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Shane Hostetter Shane Hostetter Senior Vice President, Chief Financial Officer Date: July 25, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.